Community acquired respiratory virus infections in cancer patients—Guideline on diagnosis and management by the Infectious Diseases Working Party of the German Society for haematology and Medical Oncology

European Journal of Cancer

Volumn 67, Issue , 2016, Pages 200-212

  von Lilienfeld Toal, Marie ^a,b   Berger, Annemarie ^c   Christopeit, Maximilian ^d   Hentrich, Marcus ^e   Heussel, Claus Peter ^f,g,h   Kalkreuth, Jana ^a   Klein, Michael ⁱ   Kochanek, Matthias ^j   Penack, Olaf ^k   Hauf, Elke ^l   Rieger, Christina ^m   Silling, Gerda ⁿ   Vehreschild, Maria ^j,o   Weber, Thomas ^p   Wolf, Hans Heinrich ^p   Lehners, Nicola ^f   Schalk, Enrico ^q   Mayer, Karin ^r  

^a JENA UNIVERSITY HOSPITAL   (Germany)

^b HANS KNÖLL INSTITUTE   (Germany)

^c UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^d UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^e Gynecological Hospital Red Cross   (Germany)

^f UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^g MEMBER OF THE GERMAN CENTER FOR LUNG RESEARCH DZL   (Germany)

^h UNIVERSITY OF HEIDELBERG   (Germany)

ⁱ PROSPER HOSPITAL   (Germany)

^j UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^k CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^l TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^m UNIVERSITY OF MUNICH   (Germany)

ⁿ RWTH AACHEN UNIVERSITY   (Germany)

^o UNIVERSITY OF COLOGNE   (Germany)

^p MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^q OTTO VON GUERICKE UNIVERSITY   (Germany)

^r UNIVERSITY HOSPITAL BONN   (Germany)

more..

Author keywords

Influenza; Parainfluenza; Pneumonia; Respiratory syncytial virus; Superinfection; Upper respiratory tract infection

Indexed keywords

CIDOFOVIR; IMMUNOGLOBULIN; RIBAVIRIN; SIALIDASE INHIBITOR; ANTIVIRUS AGENT; CYTOSINE; IMMUNOLOGIC FACTOR; OSELTAMIVIR; PHOSPHONIC ACID DERIVATIVE; SIALIDASE;

ADENOVIRUS INFECTION; ANTIVIRAL THERAPY; CANCER PATIENT; COMMUNITY ACQUIRED INFECTION; CONTACT ISOLATION; FACE MASK; GERMANY; HAND WASHING; HUMAN; HUMAN METAPNEUMOVIRUS INFECTION; INFECTION CONTROL; INFLUENZA; MEDICAL SOCIETY; META ANALYSIS (TOPIC); MORTALITY RATE; NOSE SMEAR; NUCLEIC ACID AMPLIFICATION; PARAINFLUENZA VIRUS INFECTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY SYNCYTIAL VIRUS INFECTION; REVIEW; SYSTEMATIC REVIEW (TOPIC); THROAT CULTURE; VIRAL RESPIRATORY TRACT INFECTION; VIRUS DIAGNOSIS; VIRUS PNEUMONIA; ADENOVIRUS INFECTIONS, HUMAN; ANALOGS AND DERIVATIVES; ANTAGONISTS AND INHIBITORS; COMMUNITY-ACQUIRED INFECTIONS; DIAGNOSTIC IMAGING; INFLUENZA, HUMAN; LUNG; MASK; METAPNEUMOVIRUS; NEOPLASMS; ONCOLOGY; PARAMYXOVIRIDAE INFECTIONS; PATIENT ISOLATION; PNEUMONIA, VIRAL; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY TRACT INFECTIONS; VIRUS DISEASES; X-RAY COMPUTED TOMOGRAPHY;

ADENOVIRUS INFECTIONS, HUMAN; ANTIVIRAL AGENTS; COMMUNITY-ACQUIRED INFECTIONS; CYTOSINE; GERMANY; HAND HYGIENE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; INFLUENZA, HUMAN; LUNG; MASKS; MEDICAL ONCOLOGY; METAPNEUMOVIRUS; NEOPLASMS; NEURAMINIDASE; NUCLEIC ACID AMPLIFICATION TECHNIQUES; ORGANOPHOSPHONATES; OSELTAMIVIR; PARAMYXOVIRIDAE INFECTIONS; PATIENT ISOLATION; PNEUMONIA, VIRAL; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY TRACT INFECTIONS; RIBAVIRIN; TOMOGRAPHY, X-RAY COMPUTED; VIRUS DISEASES;

EID: 84988654961     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2016.08.015     Document Type: Review

References (124)

1. [1] Ullmann, A.J., Cornely, O.A., Donnelly, J.P., Akova, M., Arendrup, M.C., Arikan-Akdagli, S., et al. ESCMID* guideline for the diagnosis and management of Candida diseases 2012: developing European guidelines in clinical microbiology and infectious diseases. Clin Microbiol Infect 18:Suppl. 7 (2012), 1–8.
2. [2] Mikulska, M., Del Bono, V., Gandolfo, N., Dini, S., Dominietto, A., Di Grazia, C., et al. Epidemiology of viral respiratory tract infections in an outpatient haematology facility. Ann Hematol 93:4 (2014), 669–676.
3. [3] European Centre for Disease Prevention and Control. ECDC Influenza case definitions. http://ecdc.europa.eu/en/healthtopics/influenza/surveillance/Pages/influenza_case_definitions.aspx. [Accessed 13 May 2016].
4. [4] Shachor-Meyouhas, Y., Zaidman, I., Kra-Oz, Z., Arad-Cohen, N., Kassis, I., Detection, control, and management of a respiratory syncytial virus outbreak in a pediatric hematology-oncology department. J Pediatr Hematol Oncol 35:2 (2013), 124–128.
5. [5] Milano, F., Campbell, A.P., Guthrie, K.A., Kuypers, J., Englund, J.A., Corey, L., et al. Human rhinovirus and coronavirus detection among allogeneic hematopoietic stem cell transplantation recipients. Blood 115:10 (2010), 2088–2094.
6. [6] Peck, A.J., Englund, J.A., Kuypers, J., Guthrie, K.A., Corey, L., Morrow, R., et al. Respiratory virus infection among hematopoietic cell transplant recipients: evidence for asymptomatic parainfluenza virus infection. Blood 110:5 (2007), 1681–1688.
7. [7] Harvala, H., Gaunt, E., McIntyre, C., Roddie, H., Labonte, S., Curran, E., et al. Epidemiology and clinical characteristics of parainfluenza virus 3 outbreak in a Haemato-oncology unit. J Infect 65:3 (2012), 246–254.
8. [8] Hirsch, H.H., Martino, R., Ward, K.N., Boeckh, M., Einsele, H., Ljungman, P., Fourth European Conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis and treatment of human respiratory syncytial virus, parainfluenza virus, metapneumovirus, rhinovirus, and coronavirus. Clin Infect Dis 56:2 (2013), 258–266.
9. [9] Hall, C.B., Respiratory syncytial virus and parainfluenza virus. N Engl J Med 344:25 (2001), 1917–1928.
10. [10] Nichols, W.G., Guthrie, K.A., Corey, L., Boeckh, M., Influenza infections after hematopoietic stem cell transplantation: risk factors, mortality, and the effect of antiviral therapy. Clin Infect Dis 39:9 (2004), 1300–1306.
11. [11] Nichols, W.G., Corey, L., Gooley, T., Davis, C., Boeckh, M., Parainfluenza virus infections after hematopoietic stem cell transplantation: risk factors, response to antiviral therapy, and effect on transplant outcome. Blood 98:3 (2001), 573–578.
12. [12] Lehners, N., Schnitzler, P., Geis, S., Puthenparambil, J., Benz, M.A., Alber, B., et al. Risk factors and containment of respiratory syncytial virus outbreak in a hematology and transplant unit. Bone Marrow Transplant 48:12 (2013), 1548–1553.
13. [13] Hoellein, A., Hecker, J., Hoffmann, D., Gottle, F., Protzer, U., Peschel, C., et al. Serious outbreak of human metapneumovirus in patients with hematologic malignancies. Leuk Lymphoma, 2015, 1–5.
14. [14] Abdallah, A., Rowland, K.E., Schepetiuk, S.K., To, L.B., Bardy, P., An outbreak of respiratory syncytial virus infection in a bone marrow transplant unit: effect on engraftment and outcome of pneumonia without specific antiviral treatment. Bone Marrow Transplant 32:2 (2003), 195–203.
15. [15] Jones, B.L., Clark, S., Curran, E.T., McNamee, S., Horne, G., Thakker, B., et al. Control of an outbreak of respiratory syncytial virus infection in immunocompromised adults. J Hosp Infect 44:1 (2000), 53–57.
16. [16] Chu, H.Y., Englund, J.A., Podczervinski, S., Kuypers, J., Campbell, A.P., Boeckh, M., et al. Nosocomial transmission of respiratory syncytial virus in an outpatient cancer center. Biol Blood Marrow Transplant 20:6 (2014), 844–851.
17. [17] Peck, A.J., Corey, L., Boeckh, M., Pretransplantation respiratory syncytial virus infection: impact of a strategy to delay transplantation. Clin Infect Dis 39:5 (2004), 673–680.
18. [18] Ljungman, P., Ward, K.N., Crooks, B.N., Parker, A., Martino, R., Shaw, P.J., et al. Respiratory virus infections after stem cell transplantation: a prospective study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 28:5 (2001), 479–484.
19. [19] Ljungman, P., de la Camara, R., Perez-Bercoff, L., Abecasis, M., Nieto Campuzano, J.B., Cannata-Ortiz, M.J., et al. Outcome of pandemic H1N1 infections in hematopoietic stem cell transplant recipients. Haematologica 96:8 (2011), 1231–1235.
20. [20] Chemaly, R.F., Vigil, K.J., Saad, M., Vilar-Compte, D., Cornejo-Juarez, P., Perez-Jimenez, C., et al. A multicenter study of pandemic influenza A (H1N1) infection in patients with solid tumors in 3 countries: early therapy improves outcomes. Cancer 118:18 (2012), 4627–4633.
21. [21] Choi, S.M., Xie, H., Campbell, A.P., Kuypers, J., Leisenring, W., Boudreault, A.A., et al. Influenza viral RNA detection in blood as a marker to predict disease severity in hematopoietic cell transplant recipients. J Infect Dis 206:12 (2012), 1872–1877.
22. [22] Schnell, D., Mayaux, J., de Bazelaire, C., Legoff, J., Feuillet, S., Scieux, C., et al. Risk factors for pneumonia in immunocompromised patients with influenza. Respir Med 104:7 (2010), 1050–1056.
23. [23] Debiaggi, M., Canducci, F., Sampaolo, M., Marinozzi, M.C., Parea, M., Terulla, C., et al. Persistent symptomless human metapneumovirus infection in hematopoietic stem cell transplant recipients. J Infect Dis 194:4 (2006), 474–478.
24. [24] Marcolini, J.A., Malik, S., Suki, D., Whimbey, E., Bodey, G.P., Respiratory disease due to parainfluenza virus in adult leukemia patients. Eur J Clin Microbiol Infect Dis 22:2 (2003), 79–84.
25. [25] Williams, J.V., Martino, R., Rabella, N., Otegui, M., Parody, R., Heck, J.M., et al. A prospective study comparing human metapneumovirus with other respiratory viruses in adults with hematologic malignancies and respiratory tract infections. J Infect Dis 192:6 (2005), 1061–1065.
26. [26] Renaud, C., Xie, H., Seo, S., Kuypers, J., Cent, A., Corey, L., et al. Mortality rates of human metapneumovirus and respiratory syncytial virus lower respiratory tract infections in hematopoietic cell transplantation recipients. Biol Blood Marrow Transplant 19:8 (2013), 1220–1226.
27. [27] Debur, M.C., Vidal, L.R., Stroparo, E., Nogueira, M.B., Almeida, S.M., Takahashi, G.A., et al. Human metapneumovirus infection in hematopoietic stem cell transplant recipients. Transpl Infect Dis 12:2 (2010), 173–179.
28. [28] Ustun, C., Slaby, J., Shanley, R.M., Vydra, J., Smith, A.R., Wagner, J.E., et al. Human parainfluenza virus infection after hematopoietic stem cell transplantation: risk factors, management, mortality, and changes over time. Biol Blood Marrow Transplant 18:10 (2012), 1580–1588.
29. [29] Parody, R., Rabella, N., Martino, R., Otegui, M., del Cuerpo, M., Coll, P., et al. Upper and lower respiratory tract infections by human enterovirus and rhinovirus in adult patients with hematological malignancies. Am J Hematol 82:9 (2007), 807–811.
30. [30] Khanna, N., Widmer, A.F., Decker, M., Steffen, I., Halter, J., Heim, D., et al. Respiratory syncytial virus infection in patients with hematological diseases: single-center study and review of the literature. Clin Infect Dis 46:3 (2008), 402–412.
31. [31] Shah, D.P., Ghantoji, S.S., Ariza-Heredia, E.J., Shah, J.N., El Taoum, K.K., Shah, P.K., et al. Immunodeficiency scoring index to predict poor outcomes in hematopoietic cell transplant recipients with RSV infections. Blood 123:21 (2014), 3263–3268.
32. [32] Seo, S., Xie, H., Campbell, A.P., Kuypers, J.M., Leisenring, W.M., Englund, J.A., et al. Parainfluenza virus lower respiratory tract disease after hematopoietic cell transplant: viral detection in the lung predicts outcome. Clin Infect Dis 58:10 (2014), 1357–1368.
33. [33] Cooper, R.J., Hallett, R., Tullo, A.B., Klapper, P.E., The epidemiology of adenovirus infections in Greater Manchester, UK 1982–96. Epidemiol Infect 125:2 (2000), 333–345.
34. [34] van Tol, M.J., Kroes, A.C., Schinkel, J., Dinkelaar, W., Claas, E.C., Jol-van der Zijde, C.M., et al. Adenovirus infection in paediatric stem cell transplant recipients: increased risk in young children with a delayed immune recovery. Bone Marrow Transplant 36:1 (2005), 39–50.
35. [35] Veltrop-Duits, L.A., van Vreeswijk, T., Heemskerk, B., Thijssen, J.C., El Seady, R., Jol-van der Zijde, E.M., et al. High titers of pre-existing adenovirus serotype-specific neutralizing antibodies in the host predict viral reactivation after allogeneic stem cell transplantation in children. Clin Infect Dis 52:12 (2011), 1405–1413.
36. [36] Chakrabarti, S., Mautner, V., Osman, H., Collingham, K.E., Fegan, C.D., Klapper, P.E., et al. Adenovirus infections following allogeneic stem cell transplantation: incidence and outcome in relation to graft manipulation, immunosuppression, and immune recovery. Blood 100:5 (2002), 1619–1627.
37. [37] Munoz-Cobo, B., Solano, C., Nieto, J., de la Camara, R., Remigia, M.J., Garcia-Noblejas, A., et al. Surveillance for adenovirus DNAemia early after transplantation in adult recipients of unrelated-donor allogeneic stem cell transplants in the absence of clinically suspected infection. Bone Marrow Transplant 46:11 (2011), 1484–1486.
38. [38] Ohrmalm, L., Lindblom, A., Omar, H., Norbeck, O., Gustafson, I., Lewensohn-Fuchs, I., et al. Evaluation of a surveillance strategy for early detection of adenovirus by PCR of peripheral blood in hematopoietic SCT recipients: incidence and outcome. Bone Marrow Transplant 46:2 (2011), 267–272.
39. [39] McCarthy, T., Lebeck, M.G., Capuano, A.W., Schnurr, D.P., Gray, G.C., Molecular typing of clinical adenovirus specimens by an algorithm which permits detection of adenovirus coinfections and intermediate adenovirus strains. J Clin Virol 46:1 (2009), 80–84.
40. [40] Drexler, J.F., Helmer, A., Kirberg, H., Reber, U., Panning, M., Muller, M., et al. Poor clinical sensitivity of rapid antigen test for influenza A pandemic (H1N1) 2009 virus. Emerg Infect Dis 15:10 (2009), 1662–1664.
41. [41] Ebihara, T., Endo, R., Ma, X., Ishiguro, N., Kikuta, H., Detection of human metapneumovirus antigens in nasopharyngeal secretions by an immunofluorescent-antibody test. J Clin Microbiol 43:3 (2005), 1138–1141.
42. [42] Camps Serra, M., Cervera, C., Pumarola, T., Moreno, A., Perello, R., Torres, A., et al. Virological diagnosis in community-acquired pneumonia in immunocompromised patients. Eur Respir J 31:3 (2008), 618–624.
43. [43] Costa, C., Libertucci, D., Solidoro, P., Sinesi, F., Bergallo, M., Margio, S., et al. Rapid shell vial culture for the detection of respiratory viruses from bronchoalveolar lavage in immunocompromised patients. Panminerva Med 49:1 (2007), 1–6.
44. [44] Kim, E.A., Lee, K.S., Primack, S.L., Yoon, H.K., Byun, H.S., Kim, T.S., et al. Viral pneumonias in adults: radiologic and pathologic findings. Radiographics, 22, 2002 Spec No:S137–49.
45. [45] Mayer, J.L., Lehners, N., Egerer, G., Kauczor, H.U., Heussel, C.P., CT-morphological characterization of respiratory syncytial virus (RSV) pneumonia in immune-compromised adults. Rofo 186:7 (2014), 686–692.
46. [46] Franquet, T., Rodriguez, S., Martino, R., Gimenez, A., Salinas, T., Hidalgo, A., Thin-section CT findings in hematopoietic stem cell transplantation recipients with respiratory virus pneumonia. AJR Am J Roentgenol 187:4 (2006), 1085–1090.
47. [47] Franquet, T., Rodriguez, S., Martino, R., Salinas, T., Gimenez, A., Hidalgo, A., Human metapneumovirus infection in hematopoietic stem cell transplant recipients: high-resolution computed tomography findings. J Comput Assist Tomogr 29:2 (2005), 223–227.
48. [48] Lehners, N., Tabatabai, J., Prifert, C., Wedde, M., Puthenparambil, J., Weissbrich, B., et al. Long-term shedding of influenza virus, parainfluenza virus, respiratory syncytial virus and nosocomial epidemiology in patients with hematological disorders. PLoS One, 11(2), 2016, e0148258.
49. [49] Cowling, B.J., Chan, K.H., Fang, V.J., Cheng, C.K., Fung, R.O., Wai, W., et al. Facemasks and hand hygiene to prevent influenza transmission in households: a cluster randomized trial. Ann Intern Med 151:7 (2009), 437–446.
50. [50] Hemila, H., Chalker, E., Vitamin C for preventing and treating the common cold. Cochrane Database Syst Rev, 1, 2013, CD000980.
51. [51] Karsch-Volk, M., Barrett, B., Kiefer, D., Bauer, R., Ardjomand-Woelkart, K., Linde, K., Echinacea for preventing and treating the common cold. Cochrane Database Syst Rev, 2, 2014, CD000530.
52. [52] Lissiman, E., Bhasale, A.L., Cohen, M., Garlic for the common cold. Cochrane Database Syst Rev, 11, 2014, CD006206.
53. [53] Singh, M., Das, R.R., Zinc for the common cold. Cochrane Database Syst Rev, 6, 2013, CD001364.
54. [54] Singh, M., Singh, M., Heated, humidified air for the common cold. Cochrane Database Syst Rev, 6, 2013, CD001728.
55. [55] Chen, W., Lewith, G., Wang, L.Q., Ren, J., Xiong, W.J., Lu, F., et al. Chinese proprietary herbal medicine listed in 'China national essential drug list' for common cold: a systematic literature review. PLoS One, 9(10), 2014, e110560.
56. [56] Li, S., Yue, J., Dong, B.R., Yang, M., Lin, X., Wu, T., Acetaminophen (paracetamol) for the common cold in adults. Cochrane Database Syst Rev, 7, 2013, CD008800.
57. [57] Kim, S.Y., Chang, Y.J., Cho, H.M., Hwang, Y.W., Moon, Y.S., Non-steroidal anti-inflammatory drugs for the common cold. Cochrane Database Syst Rev, 6, 2013, CD006362.
58. [58] Hayden, F.G., Diamond, L., Wood, P.B., Korts, D.C., Wecker, M.T., Effectiveness and safety of intranasal ipratropium bromide in common colds. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 125:2 (1996), 89–97.
59. [59] Genuis, S.J., Schwalfenberg, G., Siy, A.K., Rodushkin, I., Toxic element contamination of natural health products and pharmaceutical preparations. PLoS One, 7(11), 2012, e49676.
60. [60] Kenealy, T., Arroll, B., Antibiotics for the common cold and acute purulent rhinitis. Cochrane Database Syst Rev, 6, 2013, CD000247.
61. [61] Aslan, T., Fassas, A.B., Desikan, R., Siegel, D., Munshi, N., Mehta, J., et al. Patients with multiple myeloma may safely undergo autologous transplantation despite ongoing RSV infection and no ribavirin therapy. Bone Marrow Transplant 24:5 (1999), 505–509.
62. [62] Avivi, I., Chakrabarti, S., Milligan, D.W., Waldmann, H., Hale, G., Osman, H., et al. Incidence and outcome of adenovirus disease in transplant recipients after reduced-intensity conditioning with alemtuzumab. Biol Blood Marrow Transplant 10:3 (2004), 186–194.
63. [63] Fiore, A.E., Fry, A., Shay, D., Gubareva, L., Bresee, J.S., Uyeki, T.M., Antiviral agents for the treatment and chemoprophylaxis of influenza – recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 60:1 (2011), 1–24.
64. [64] Bright, R.A., Shay, D.K., Shu, B., Cox, N.J., Klimov, A.I., Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States. JAMA 295:8 (2006), 891–894.
65. [65] Englund, J.A., Champlin, R.E., Wyde, P.R., Kantarjian, H., Atmar, R.L., Tarrand, J., et al. Common emergence of amantadine- and rimantadine-resistant influenza A viruses in symptomatic immunocompromised adults. Clin Infect Dis 26:6 (1998), 1418–1424.
66. [66] Hayden, F.G., Sperber, S.J., Belshe, R.B., Clover, R.D., Hay, A.J., Pyke, S., Recovery of drug-resistant influenza A virus during therapeutic use of rimantadine. Antimicrob Agents Chemother 35:9 (1991), 1741–1747.
67. [67] Dobson, J., Whitley, R.J., Pocock, S., Monto, A.S., Oseltamivir treatment for influenza in adults: a meta-analysis of randomised controlled trials. Lancet 385:9979 (2015), 1729–1737.
68. [68] Jefferson, T., Jones, M.A., Doshi, P., Del Mar, C.B., Hama, R., Thompson, M.J., et al. Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children. Cochrane Database Syst Rev, 4, 2014, CD008965.
69. [69] Casper, C., Englund, J., Boeckh, M., How I treat influenza in patients with hematologic malignancies. Blood 115:7 (2010), 1331–1342.
70. [70] Engelhard, D., Mohty, B., de la Camara, R., Cordonnier, C., Ljungman, P., European guidelines for prevention and management of influenza in hematopoietic stem cell transplantation and leukemia patients: summary of ECIL-4 (2011), on behalf of ECIL, a joint venture of EBMT, EORTC, ICHS, and ELN. Transpl Infect Dis 15:3 (2013), 219–232.
71. [71] Vu, D., Peck, A.J., Nichols, W.G., Varley, C., Englund, J.A., Corey, L., et al. Safety and tolerability of oseltamivir prophylaxis in hematopoietic stem cell transplant recipients: a retrospective case-control study. Clin Infect Dis 45:2 (2007), 187–193.
72. [72] Tomblyn, M., Chiller, T., Einsele, H., Gress, R., Sepkowitz, K., Storek, J., et al. Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective. Biol Blood Marrow Transplant 15:10 (2009), 1143–1238.
73. [73] Chemaly, R.F., Shah, D.P., Boeckh, M.J., Management of respiratory viral infections in hematopoietic cell transplant recipients and patients with hematologic malignancies. Clin Infect Dis 59:Suppl. 5 (2014), S344–S351.
74. [74] Machado, C.M., Boas, L.S., Mendes, A.V., da Rocha, I.F., Sturaro, D., Dulley, F.L., et al. Use of oseltamivir to control influenza complications after bone marrow transplantation. Bone Marrow Transplant 34:2 (2004), 111–114.
75. [75] Johny, A.A., Clark, A., Price, N., Carrington, D., Oakhill, A., Marks, D.I., The use of zanamivir to treat influenza A and B infection after allogeneic stem cell transplantation. Bone Marrow Transplant 29:2 (2002), 113–115.
76. [76] Chemaly, R.F., Torres, H.A., Aguilera, E.A., Mattiuzzi, G., Cabanillas, M., Kantarjian, H., et al. Neuraminidase inhibitors improve outcome of patients with leukemia and influenza: an observational study. Clin Infect Dis 44:7 (2007), 964–967.
77. [77] Choi, S.M., Boudreault, A.A., Xie, H., Englund, J.A., Corey, L., Boeckh, M., Differences in clinical outcomes after 2009 influenza A/H1N1 and seasonal influenza among hematopoietic cell transplant recipients. Blood 117:19 (2011), 5050–5056.
78. [78] Birnkrant, D., Cox, E., The emergency use authorization of peramivir for treatment of 2009 H1N1 influenza. N Engl J Med 361:23 (2009), 2204–2207.
79. [79] Sparrelid, E., Ljungman, P., Ekelof-Andstrom, E., Aschan, J., Ringden, O., Winiarski, J., et al. Ribavirin therapy in bone marrow transplant recipients with viral respiratory tract infections. Bone Marrow Transplant 19:9 (1997), 905–908.
80. [80] Shah, J.N., Chemaly, R.F., Management of RSV infections in adult recipients of hematopoietic stem cell transplantation. Blood 117:10 (2011), 2755–2763.
81. [81] Marcelin, J.R., Wilson, J.W., Razonable, R.R., Oral ribavirin therapy for respiratory syncytial virus infections in moderately to severely immunocompromised patients. Transpl Infect Dis 16:2 (2014), 242–250.
82. [82] Shah, D.P., Ghantoji, S.S., Shah, J.N., El Taoum, K.K., Jiang, Y., Popat, U., et al. Impact of aerosolized ribavirin on mortality in 280 allogeneic haematopoietic stem cell transplant recipients with respiratory syncytial virus infections. J Antimicrob Chemother 68:8 (2013), 1872–1880.
83. [83] Mendes, E.T., Ramos, J., Peixoto, D., Dulley, F., Alves, T., Vilas Boas, L.S., et al. An outbreak of respiratory syncytial virus infection in hematopoietic stem cell transplantation outpatients: good outcome without specific antiviral treatment. Transpl Infect Dis 15:1 (2013), 42–48.
84. [84] Anaissie, E.J., Mahfouz, T.H., Aslan, T., Pouli, A., Desikan, R., Fassas, A., et al. The natural history of respiratory syncytial virus infection in cancer and transplant patients: implications for management. Blood 103:5 (2004), 1611–1617.
85. [85] Kilham, L., Ferm, V.H., Congenital anomalies induced in hamster embryos with ribavirin. Science 195:4276 (1977), 413–414.
86. [86] Casey, J., Morris, K., Narayana, M., Nakagaki, M., Kennedy, G.A., Oral ribavirin for treatment of respiratory syncitial virus and parainfluenza 3 virus infections post allogeneic haematopoietic stem cell transplantation. Bone Marrow Transplant 48:12 (2013), 1558–1561.
87. [87] Gueller, S., Duenzinger, U., Wolf, T., Ajib, S., Mousset, S., Berger, A., et al. Successful systemic high-dose ribavirin treatment of respiratory syncytial virus-induced infections occurring pre-engraftment in allogeneic hematopoietic stem cell transplant recipients. Transpl Infect Dis 15:4 (2013), 435–440.
88. [88] Maziarz, R.T., Sridharan, P., Slater, S., Meyers, G., Post, M., Erdman, D.D., et al. Control of an outbreak of human parainfluenza virus 3 in hematopoietic stem cell transplant recipients. Biol Blood Marrow Transplant 16:2 (2010), 192–198.
89. [89] Hohenthal, U., Nikoskelainen, J., Vainionpaa, R., Peltonen, R., Routamaa, M., Itala, M., et al. Parainfluenza virus type 3 infections in a hematology unit. Bone Marrow Transplant 27:3 (2001), 295–300.
90. [90] Hromas, R., Cornetta, K., Srour, E., Blanke, C., Broun, E.R., Donor leukocyte infusion as therapy of life-threatening adenoviral infections after T-cell-depleted bone marrow transplantation. Blood 84:5 (1994), 1689–1690.
91. [91] Geyeregger, R., Freimuller, C., Stemberger, J., Artwohl, M., Witt, V., Lion, T., et al. First-in-man clinical results with good manufacturing practice (GMP)-compliant polypeptide-expanded adenovirus-specific T cells after haploidentical hematopoietic stem cell transplantation. J Immunother 37:4 (2014), 245–249.
92. [92] Egli, A., Bucher, C., Dumoulin, A., Stern, M., Buser, A., Bubendorf, L., et al. Human metapneumovirus infection after allogeneic hematopoietic stem cell transplantation. Infection 40:6 (2012), 677–684.
93. [93] Englund, J.A., Boeckh, M., Kuypers, J., Nichols, W.G., Hackman, R.C., Morrow, R.A., et al. Brief communication: fatal human metapneumovirus infection in stem-cell transplant recipients. Ann Intern Med 144:5 (2006), 344–349.
94. [94] Ison, M.G., Michaels, M.G., RNA respiratory viral infections in solid organ transplant recipients. Am J Transplant 9:Suppl. 4 (2009), S166–S172.
95. [95] Covalciuc, K.A., Webb, K.H., Carlson, C.A., Comparison of four clinical specimen types for detection of influenza A and B viruses by optical immunoassay (FLU OIA test) and cell culture methods. J Clin Microbiol 37:12 (1999), 3971–3974.
96. [96] Kaiser, L., Briones, M.S., Hayden, F.G., Performance of virus isolation and Directigen Flu A to detect influenza A virus in experimental human infection. J Clin Virol 14:3 (1999), 191–197.
97. [97] Debyle, C., Bulkow, L., Miernyk, K., Chikoyak, L., Hummel, K.B., Hennessy, T., et al. Comparison of nasopharyngeal flocked swabs and nasopharyngeal wash collection methods for respiratory virus detection in hospitalized children using real-time polymerase chain reaction. J Virol Methods 185:1 (2012), 89–93.
98. [98] Heikkinen, T., Marttila, J., Salmi, A.A., Ruuskanen, O., Nasal swab versus nasopharyngeal aspirate for isolation of respiratory viruses. J Clin Microbiol 40:11 (2002), 4337–4339.
99. [99] Li, L., Chen, Q.Y., Li, Y.Y., Wang, Y.F., Yang, Z.F., Zhong, N.S., Comparison among nasopharyngeal swab, nasal wash, and oropharyngeal swab for respiratory virus detection in adults with acute pharyngitis. BMC Infect Dis, 13, 2013, 281.
100. [100] Macfarlane, P., Denham, J., Assous, J., Hughes, C., RSV testing in bronchiolitis: which nasal sampling method is best?. Arch Dis Child 90:6 (2005), 634–635.
101. [101] Meerhoff, T.J., Houben, M.L., Coenjaerts, F.E., Kimpen, J.L., Hofland, R.W., Schellevis, F., et al. Detection of multiple respiratory pathogens during primary respiratory infection: nasal swab versus nasopharyngeal aspirate using real-time polymerase chain reaction. Eur J Clin Microbiol Infect Dis 29:4 (2010), 365–371.
102. [102] Sung, R.Y., Chan, P.K., Choi, K.C., Yeung, A.C., Li, A.M., Tang, J.W., et al. Comparative study of nasopharyngeal aspirate and nasal swab specimens for diagnosis of acute viral respiratory infection. J Clin Microbiol 46:9 (2008), 3073–3076.
103. [103] Waris, M., Osterback, R., Lahti, E., Vuorinen, T., Ruuskanen, O., Peltola, V., Comparison of sampling methods for the detection of human rhinovirus RNA. J Clin Virol 58:1 (2013), 200–204.
104. [104] Kuypers, J., Campbell, A.P., Cent, A., Corey, L., Boeckh, M., Comparison of conventional and molecular detection of respiratory viruses in hematopoietic cell transplant recipients. Transpl Infect Dis 11:4 (2009), 298–303.
105. [105] Falsey, A.R., Formica, M.A., Treanor, J.J., Walsh, E.E., Comparison of quantitative reverse transcription-PCR to viral culture for assessment of respiratory syncytial virus shedding. J Clin Microbiol 41:9 (2003), 4160–4165.
106. [106] Hindiyeh, M., Hillyard, D.R., Carroll, K.C., Evaluation of the Prodesse Hexaplex multiplex PCR assay for direct detection of seven respiratory viruses in clinical specimens. Am J Clin Pathol 116:2 (2001), 218–224.
107. [107] Chen, K.F., Rothman, R.E., Ramachandran, P., Blyn, L., Sampath, R., Ecker, D.J., et al. Rapid identification viruses from nasal pharyngeal aspirates in acute viral respiratory infections by RT-PCR and electrospray ionization mass spectrometry. J Virol Methods 173:1 (2011), 60–66.
108. [108] Abbo, L., Quartin, A., Morris, M.I., Saigal, G., Ariza-Heredia, E., Mariani, P., et al. Pulmonary imaging of pandemic influenza H1N1 infection: relationship between clinical presentation and disease burden on chest radiography and CT. Br J Radiol 83:992 (2010), 645–651.
109. [109] Chandler, T.M., Leipsic, J., Nicolaou, S., Quiney, B., Romney, M., Muller, N.L., et al. Confirmed swine-origin influenza A(H1N1) viral pneumonia: computed tomographic findings in the immunocompetent and the immunocompromised. J Comput Assist Tomogr 35:5 (2011), 602–607.
110. [110] El-Badrawy, A., Zeidan, A., Ebrahim, M.A., 64 multidetector CT findings of influenza A (H1N1) virus in patients with hematologic malignancies. Acta Radiol 53:6 (2012), 662–667.
111. [111] Elicker, B.M., Schwartz, B.S., Liu, C., Chen, E.C., Miller, S.A., Chiu, C.Y., et al. Thoracic CT findings of novel influenza A (H1N1) infection in immunocompromised patients. Emerg Radiol 17:4 (2010), 299–307.
112. [112] Ko, J.P., Shepard, J.A., Sproule, M.W., Trotman-Dickenson, B., Drucker, E.A., Ginns, L.C., et al. CT manifestations of respiratory syncytial virus infection in lung transplant recipients. J Comput Assist Tomogr 24:2 (2000), 235–241.
113. [113] Laqmani, A., Adam, G., Regier, M., Pulmonary manifestation of novel swine-origin influenza A (H1N1) virus (S-OIV) infection in immunocompromised patients: initial findings with multidetector computed tomography. Med Princ Pract 21:6 (2012), 548–553.
114. [114] Oikonomou, A., Muller, N.L., Nantel, S., Radiographic and high-resolution CT findings of influenza virus pneumonia in patients with hematologic malignancies. AJR Am J Roentgenol 181:2 (2003), 507–511.
115. [115] Syha, R., Beck, R., Hetzel, J., Ketelsen, D., Grosse, U., Springer, F., et al. Human metapneumovirus (HMPV) associated pulmonary infections in immunocompromised adults–initial CT findings, disease course and comparison to respiratory-syncytial-virus (RSV) induced pulmonary infections. Eur J Radiol 81:12 (2012), 4173–4178.
116. [116] Jefferson, T., Del Mar, C.B., Dooley, L., Ferroni, E., Al-Ansary, L.A., Bawazeer, G.A., et al. Physical interventions to interrupt or reduce the spread of respiratory viruses. Cochrane Database Syst Rev(7), 2011, CD006207.
117. [117] RSV Outbreak Investigation Team. Contributing and terminating factors of a large RSV outbreak in an Adult Hematology and Transplant Unit. PLoS Curr, 2014, 6.
118. [118] Falsey, A.R., Current management of parainfluenza pneumonitis in immunocompromised patients: a review. Infect Drug Resist 5 (2012), 121–127.
119. [119] Gokturk, B., Pekcan, S., Guner, S.N., Artac, H., Keles, S., Kirac, M., et al. Efficacy of intravenous immunoglobulin treatment in immunocompromised children with H1N1 influenza: a clinical observation. Clin Respir J 10:2 (2016 Mar), 223–230.
120. [120] Ljungman, P., Ribaud, P., Eyrich, M., Matthes-Martin, S., Einsele, H., Bleakley, M., et al. Cidofovir for adenovirus infections after allogeneic hematopoietic stem cell transplantation: a survey by the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 31:6 (2003), 481–486.
121. [121] Robin, M., Marque-Juillet, S., Scieux, C., Peffault de Latour, R., Ferry, C., Rocha, V., et al. Disseminated adenovirus infections after allogeneic hematopoietic stem cell transplantation: incidence, risk factors and outcome. Haematologica 92:9 (2007), 1254–1257.
122. [122] Legrand, F., Berrebi, D., Houhou, N., Freymuth, F., Faye, A., Duval, M., et al. Early diagnosis of adenovirus infection and treatment with cidofovir after bone marrow transplantation in children. Bone Marrow Transplant 27:6 (2001), 621–626.
123. [123] Leruez-Ville, M., Chardin-Ouachee, M., Neven, B., Picard, C., Le Guinche, I., Fischer, A., et al. Description of an adenovirus A31 outbreak in a paediatric haematology unit. Bone Marrow Transplant 38:1 (2006), 23–28.
124. [124] Nicolasora, N.P., Reddy, P., Kaul, D.R., Biopsy-proven adenoviral diarrhea responding to low-dose cidofovir. Transpl Infect Dis 10:5 (2008), 346–350.